JW Life Science (234080.KS) Stock Price

JW Life Science Price

KOSDAQ·CLOSED
11,510.00KRW+130.00 (+1.14 %)
Market closed

Over the last 10 years JW Life Science grew revenue by 7.2% annually, reaching 222.48 B KRW. Earnings per share have grown at 17.1% per year over the last 10 years. For JW Life Science, the net margin of 19.8% is up versus 9.2% a few years ago. At today's price the dividend yield works out to roughly 4.34%. The payout ratio is around 18% of earnings. The consensus 12-month price target for JW Life Science is 18,360.00 KRW, about 59.5% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 7% above its 52-week low.

JW Life Science stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of JW Life Science over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how JW Life Science stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing JW Life Science's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

JW Life Science Stock Price History
DateJW Life Science Price
8/7/202611,510.00 KRW
8/6/202611,380.00 KRW
8/5/202611,300.00 KRW
8/4/202611,170.00 KRW
8/3/202611,150.00 KRW
7/31/202611,010.00 KRW
7/30/202610,930.00 KRW
7/29/202610,760.00 KRW
7/28/202610,720.00 KRW
7/27/202611,230.00 KRW
7/24/202611,090.00 KRW
7/23/202611,090.00 KRW
7/22/202610,860.00 KRW
7/21/202611,030.00 KRW
7/20/202611,190.00 KRW
7/16/202611,380.00 KRW
7/15/202611,220.00 KRW
7/14/202611,125.00 KRW
7/13/202611,160.00 KRW
7/10/202611,390.00 KRW
7/9/202611,170.00 KRW
7/8/202611,450.00 KRW
7/7/202611,620.00 KRW
7/6/202611,740.00 KRW
7/3/202611,440.00 KRW
7/2/202611,320.00 KRW
7/1/202611,420.00 KRW
6/30/202611,420.00 KRW
6/29/202611,390.00 KRW
6/26/202610,980.00 KRW
6/25/202611,120.00 KRW
6/24/202611,020.00 KRW
6/23/202610,950.00 KRW
6/22/202611,230.00 KRW
6/19/202611,360.00 KRW
6/18/202611,400.00 KRW
6/17/202611,530.00 KRW
6/16/202611,480.00 KRW
6/15/202611,530.00 KRW
6/12/202611,410.00 KRW
6/11/202611,180.00 KRW
6/10/202611,010.00 KRW
6/9/202611,200.00 KRW
6/8/202610,730.00 KRW
6/5/202611,040.00 KRW
6/4/202611,110.00 KRW
6/2/202611,250.00 KRW
6/1/202611,140.00 KRW
5/29/202611,360.00 KRW
5/28/202611,560.00 KRW
5/27/202611,570.00 KRW
5/26/202611,790.00 KRW
5/22/202612,100.00 KRW
5/21/202611,710.00 KRW
5/20/202611,690.00 KRW
5/19/202611,890.00 KRW
5/18/202612,040.00 KRW
5/15/202612,030.00 KRW
5/14/202612,400.00 KRW
5/13/202612,210.00 KRW
5/12/202612,420.00 KRW
5/11/202612,600.00 KRW
5/8/202612,880.00 KRW
5/7/202612,630.00 KRW
5/6/202612,560.00 KRW
5/4/202612,820.00 KRW
4/30/202612,930.00 KRW
4/29/202613,100.00 KRW
4/28/202613,100.00 KRW
4/27/202612,950.00 KRW
4/24/202612,960.00 KRW
4/23/202612,840.00 KRW
4/22/202612,780.00 KRW
4/21/202612,860.00 KRW
4/20/202612,950.00 KRW
4/17/202612,970.00 KRW
4/16/202613,000.00 KRW
4/15/202612,930.00 KRW
4/14/202612,740.00 KRW
4/13/202612,700.00 KRW
4/10/202612,780.00 KRW
4/9/202612,480.00 KRW
4/8/202612,670.00 KRW
4/7/202612,430.00 KRW
4/6/202612,500.00 KRW
4/3/202612,670.00 KRW
4/2/202612,620.00 KRW
4/1/202612,910.00 KRW
3/31/202612,560.00 KRW
3/30/202613,240.00 KRW
3/27/202613,280.00 KRW
3/26/202613,170.00 KRW
3/25/202613,360.00 KRW
3/24/202613,100.00 KRW
3/23/202612,770.00 KRW
3/20/202613,180.00 KRW
3/19/202612,980.00 KRW
3/18/202613,130.00 KRW
3/17/202613,080.00 KRW
3/16/202613,000.00 KRW
3/13/202613,140.00 KRW
3/12/202613,220.00 KRW
3/11/202612,940.00 KRW
3/10/202612,710.00 KRW
3/9/202612,490.00 KRW
3/6/202612,930.00 KRW
3/5/202612,930.00 KRW
2/26/202613,690.00 KRW
2/25/202613,650.00 KRW
2/24/202613,730.00 KRW
2/23/202613,910.00 KRW
2/20/202613,620.00 KRW
2/19/202613,480.00 KRW
2/13/202613,240.00 KRW
2/12/202613,410.00 KRW
2/11/202613,160.00 KRW
2/10/202613,140.00 KRW
2/9/202612,670.00 KRW
2/6/202612,810.00 KRW
2/5/202612,950.00 KRW
2/4/202613,080.00 KRW
2/3/202612,740.00 KRW
2/2/202612,460.00 KRW
1/30/202612,910.00 KRW
1/29/202613,040.00 KRW
1/28/202612,710.00 KRW
1/27/202612,740.00 KRW
1/26/202612,840.00 KRW
1/23/202612,910.00 KRW
1/22/202612,530.00 KRW
1/21/202612,360.00 KRW
1/20/202612,630.00 KRW
1/19/202612,420.00 KRW
1/16/202612,450.00 KRW
1/15/202612,460.00 KRW
1/14/202612,580.00 KRW
1/13/202612,550.00 KRW
1/12/202612,630.00 KRW
1/9/202612,580.00 KRW
1/8/202612,700.00 KRW
1/7/202612,590.00 KRW
1/6/202612,870.00 KRW
1/5/202612,800.00 KRW
1/2/202612,810.00 KRW
12/30/202512,850.00 KRW
12/29/202512,820.00 KRW
12/26/202513,410.00 KRW
12/24/202513,400.00 KRW
12/23/202513,600.00 KRW
12/22/202513,950.00 KRW
12/19/202514,280.00 KRW
12/18/202514,670.00 KRW
12/17/202514,630.00 KRW
12/16/202514,340.00 KRW
12/15/202514,370.00 KRW
12/12/202513,970.00 KRW
12/11/202514,110.00 KRW
12/10/202513,920.00 KRW
12/9/202513,670.00 KRW
12/8/202513,750.00 KRW
12/5/202513,660.00 KRW
12/4/202513,750.00 KRW
12/3/202514,770.00 KRW
12/2/202515,180.00 KRW
12/1/202515,050.00 KRW
11/28/202514,970.00 KRW
11/27/202514,780.00 KRW
11/26/202515,200.00 KRW
11/25/202514,550.00 KRW
11/24/202514,870.00 KRW
11/21/202515,300.00 KRW
11/20/202515,200.00 KRW
11/19/202514,960.00 KRW
11/18/202515,500.00 KRW
11/17/202515,210.00 KRW
11/14/202514,990.00 KRW
11/13/202514,605.00 KRW
11/12/202514,320.00 KRW
11/11/202513,930.00 KRW
11/10/202513,550.00 KRW
11/7/202513,010.00 KRW
11/6/202513,170.00 KRW
11/5/202513,210.00 KRW
11/4/202513,860.00 KRW
11/3/202513,780.00 KRW
10/31/202513,450.00 KRW
10/30/202513,450.00 KRW
10/29/202513,580.00 KRW
10/28/202513,360.00 KRW
10/27/202513,080.00 KRW
10/24/202513,300.00 KRW
10/23/202513,430.00 KRW
10/22/202513,400.00 KRW
10/21/202512,800.00 KRW
10/20/202512,570.00 KRW
10/17/202512,510.00 KRW
10/16/202512,650.00 KRW
10/15/202512,710.00 KRW
10/14/202512,480.00 KRW
10/13/202512,550.00 KRW
10/10/202512,500.00 KRW
10/2/202512,600.00 KRW
10/1/202512,470.00 KRW
9/30/202512,370.00 KRW
9/29/202512,510.00 KRW
9/26/202512,250.00 KRW
9/25/202512,420.00 KRW
9/24/202512,400.00 KRW
9/23/202512,350.00 KRW
9/22/202512,360.00 KRW
9/19/202512,090.00 KRW
9/18/202511,940.00 KRW
9/17/202511,850.00 KRW
9/16/202511,930.00 KRW
9/15/202511,950.00 KRW
9/12/202511,950.00 KRW
9/11/202512,000.00 KRW
9/10/202511,980.00 KRW
9/9/202511,870.00 KRW
9/8/202511,870.00 KRW
9/5/202511,730.00 KRW
9/4/202511,690.00 KRW
9/3/202511,630.00 KRW
9/2/202511,480.00 KRW
9/1/202511,500.00 KRW
8/29/202511,540.00 KRW
8/28/202511,470.00 KRW
8/27/202511,540.00 KRW
8/26/202511,510.00 KRW
8/25/202511,650.00 KRW
8/22/202511,430.00 KRW
8/21/202511,400.00 KRW
8/20/202511,490.00 KRW
8/19/202511,630.00 KRW
8/18/202511,820.00 KRW
8/14/202512,010.00 KRW
8/13/202512,090.00 KRW
8/12/202512,020.00 KRW
8/11/202512,070.00 KRW
Access this data via the Eulerpool API
Get Free API Key

JW Life Science Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
169.82 B KRW
28.42 B KRW
12.91 B KRW
Jan 1, 2022
188.93 B KRW
27.09 B KRW
14.96 B KRW
Jan 1, 2023
206.86 B KRW
30.86 B KRW
28.14 B KRW
Jan 1, 2024
222.48 B KRW
35.86 B KRW
43.99 B KRW
Jan 1, 2025 (e)
243.50 B KRW
42.37 B KRW
28.85 B KRW
Jan 1, 2026 (e)
273.90 B KRW
47.66 B KRW
27.39 B KRW
Jan 1, 2027 (e)
293.80 B KRW
51.12 B KRW
29.23 B KRW
Jan 1, 2028 (e)
315.30 B KRW
54.86 B KRW
31.36 B KRW

JW Life Science Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 10, 2026, 8:04 AM
 
REVENUEB KRW
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB KRW
EBITB KRW
EBIT MARGIN%
NET INCOMEB KRW
NET INCOME GROWTH%
DIV.KRW
DIV. GROWTH%
SHARESM
201420152016201720182019202020212022202320242025e2026e2027e2028e
111.12125.95132.29143.60155.23170.22183.52169.82188.93206.86222.48243.50273.90293.80315.30
–13.345.038.558.109.667.81-7.4711.269.497.559.4512.487.277.32
22.1923.9825.9125.8925.4628.5532.4228.9525.4725.3325.8525.8525.8525.8525.85
24.6630.2034.2837.1839.5248.6159.5049.1648.1252.3957.5162.9470.8075.9481.50
14.6118.6621.6323.7823.5429.7539.4528.4227.0930.8635.8642.3747.6651.1254.86
13.1514.8116.3516.5615.1717.4821.5016.7314.3414.9216.1217.4017.4017.4017.40
9.3612.8615.1616.7815.8221.9416.8712.9114.9628.1443.9928.8527.3929.2331.36
–37.4817.8610.69-5.7338.66-23.12-23.4415.8688.1256.29-34.42-5.046.727.26
––600.001,000.00500.00500.00500.00500.00500.00500.00500.00500.00500.00500.00–
–––66.67-50.00––––––––––
16.0016.0016.0016.0016.0016.0016.0015.5815.4815.4815.4815.4815.4815.4815.48
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales JW Life Science generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue JW Life Science retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare JW Life Science's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares JW Life Science has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against JW Life Science's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

JW Life Science stock margins

The JW Life Science margin analysis displays the gross margin, EBIT margin, as well as the profit margin of JW Life Science. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for JW Life Science.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
32.42 %
21.50 %
9.19 %
Jan 1, 2021
28.95 %
16.73 %
7.60 %
Jan 1, 2022
25.47 %
14.34 %
7.92 %
Jan 1, 2023
25.33 %
14.92 %
13.61 %
Jan 1, 2024
25.85 %
16.12 %
19.77 %
Jan 1, 2025 (e)
25.85 %
17.40 %
11.85 %
Jan 1, 2026 (e)
25.85 %
17.40 %
10.00 %
Jan 1, 2027 (e)
25.85 %
17.40 %
9.95 %

JW Life Science Stock Revenue, EBIT, Earnings per Share

The JW Life Science earnings per share therefore indicates how much revenue JW Life Science has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
11,470.06 KRW
2,465.69 KRW
1,054.19 KRW
Jan 1, 2021
10,899.47 KRW
1,823.89 KRW
828.84 KRW
Jan 1, 2022
12,201.23 KRW
1,749.43 KRW
966.20 KRW
Jan 1, 2023
13,359.10 KRW
1,993.07 KRW
1,817.55 KRW
Jan 1, 2024
14,367.70 KRW
2,315.72 KRW
2,840.73 KRW
Jan 1, 2025 (e)
15,725.30 KRW
2,736.03 KRW
1,863.00 KRW
Jan 1, 2026 (e)
17,688.54 KRW
3,077.61 KRW
1,769.00 KRW
Jan 1, 2027 (e)
18,973.69 KRW
3,301.21 KRW
1,888.00 KRW

JW Life Science business model & stock analysis

JW Life Science Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

JW Life Science historical P/E ratio, EBIT multiple, and P/S ratio

JW Life Science annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

JW Life Science shares outstanding

The number of shares of JW Life Science was 15.48 M in 2025. This indicates how many shares JW Life Science is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
16.00 M Stocks
Jan 1, 2021
15.58 M Stocks
Jan 1, 2022
15.48 M Stocks
Jan 1, 2023
15.48 M Stocks
Jan 1, 2024
15.48 M Stocks
Jan 1, 2025 (e)
15.48 M Stocks
Jan 1, 2026 (e)
15.48 M Stocks
Jan 1, 2027 (e)
15.48 M Stocks

JW Life Science stock splits

In JW Life Science's history, there have been no stock splits.

JW Life Science Dividend History

10 years of dividend payments

YearAnnual DividendYoY ChangePayments
2026550.00KRWYTD—1×
Mar 31, 2026550.00KRW↑ 10.0%1/1
2024500.00KRW 0.0%1×
2023500.00KRW 0.0%1×
2022500.00KRW 0.0%1×
2021500.00KRW 0.0%1×
2020500.00KRW 0.0%1×
2019500.00KRW 0.0%1×
2018500.00KRW↓ 50.0%1×
20171,000.00KRW↑ 66.7%1×
2016600.00KRW—1×

JW Life Science dividend history and estimates

In 2025, JW Life Science paid a dividend amounting to 500.00 KRW. Dividend means that JW Life Science distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2020
500.00 KRW
0.00 KRW
Jan 1, 2021
500.00 KRW
0.00 KRW
Jan 1, 2022
500.00 KRW
0.00 KRW
Jan 1, 2023
500.00 KRW
0.00 KRW
Jan 1, 2024
500.00 KRW
0.00 KRW
Jan 1, 2025 (e)
0.00 KRW
500.00 KRW
Jan 1, 2026 (e)
0.00 KRW
500.00 KRW
Jan 1, 2027 (e)
0.00 KRW
500.00 KRW

JW Life Science dividend payout ratio

In 2025, JW Life Science had a payout ratio of 26.84%. The payout ratio indicates the percentage of the company's profits that JW Life Science distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2020
47.43 %
Jan 1, 2021
60.33 %
Jan 1, 2022
51.75 %
Jan 1, 2023
27.51 %
Jan 1, 2024
17.60 %
Jan 1, 2025 (e)
26.84 %
Jan 1, 2026 (e)
28.26 %
Jan 1, 2027 (e)
26.48 %

Current JW Life Science forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
80.00 % (4)
Hold
20.00 % (1)
Sell
0.00 % (0)
12M Price Target
18,360.00
Last Price
11,710.00
Currency
KRW
12M Return Potential
56.79 %
LTM Return
0 %

JW Life Science shareholder structure

% Name
7.07801%
FIL Investment Management (Singapore) Ltd.
FIL Investment Management (Singapore) Ltd.
2.11516%
Fidelity International
Fidelity International
0.74648%
Dimensional Fund Advisors, L.P.
Dimensional Fund Advisors, L.P.
0.24218%
Fidelity Management & Research Company LLC
Fidelity Management & Research Company LLC
0.13298%
Dimensional Fund Advisors, Ltd.
Dimensional Fund Advisors, Ltd.
0.10662%
Hanwha Asset Management Co., Ltd.
Hanwha Asset Management Co., Ltd.

JW Life Science Beneficial Ownership Filings (SEC 13D/G)

Free Float
55.3%
Float Shares
-
Shares Outstanding
-

JW Life Science Executives and Management Board

5 members · avg. age 70

Management

JN

Jeong Yeol Noh

Chief Executive Officer, Director · since 2024

–
CP

Cheol Won Park (72)

Internal Auditor

–

Board of Directors

JG

Jae Cheol Gwon

Non Executive Director

–
YL

Yin Sik Lee

Non Executive Director

–
HK

Mr. Hak Ju Kim (67)

Non-Executive Independent Director

–

JW Life Science Supply Chain

JW Life Science Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
JW Shinyak
Supplier·Customer·Pharmaceuticals·KR
0.27
0.40
0.25
0.38
0.18
0.60

Frequently asked questions about JW Life Science

Analysts currently set an average price target of 18,360.00 KRW for the JW Life Science stock (median: 18,360.00 KRW), implying +56.8 % versus the latest price. The consensus is based on 5 analyst ratings.

JW Life Science Analyst Price Targets 2026

5 analysts currently rate the JW Life Science stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect JW Life Science to generate revenue of 273.90 B KRW and earnings per share of 1,769.00 KRW.

JW Life Science Analyst Price Targets 2026

Converted at the current exchange rate, the JW Life Science share trades at 7.06 EUR (11,510.00 KRW).

No history available for JW Life Science.

The expected revenue of JW Life Science is 273.90 B KRW. This figure is based on current financial data and reflects the company's business performance.

The expected profit of JW Life Science is 27.39 B KRW. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of JW Life Science is currently 6.51. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the JW Life Science stock.

The price-to-sales ratio (P/S) of JW Life Science is currently 0.65. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the JW Life Science stock.

The Eulerpool Quality Score for JW Life Science is 8/10.

The ISIN of JW Life Science is KR7234080000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of JW Life Science is 234080.KS. The ticker symbol is used to trade JW Life Science shares on the stock exchange.

Over the past 12 months, JW Life Science paid a dividend of 500.00 KRW . This corresponds to a dividend yield of about 4.34 %. For the coming 12 months, JW Life Science is expected to pay a dividend of 500.00 KRW.

The current dividend yield of JW Life Science is 4.34 %.

JW Life Science pays a dividend, distributed in the months of , , , .

JW Life Science paid dividends every year for the past 0 years.

For the upcoming 12 months, dividends amounting to 500.00 KRW are expected. This corresponds to a dividend yield of 4.34 %.

JW Life Science is assigned to the 'Health' sector.

To receive the latest dividend of JW Life Science from amounting to 550 KRW, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, JW Life Science distributed 500 KRW as dividends.

The dividends of JW Life Science are distributed in KRW.

All fundamentals and in-depth analysis of JW Life Science

Our stock analysis for JW Life Science stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of JW Life Science. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

JW Life Science Stock
JW Life Science Revenue→
JW Life Science Stock
JW Life Science Net Income→
JW Life Science Stock
JW Life Science P/E→
JW Life Science Stock
JW Life Science P/S→
JW Life Science Stock
JW Life Science EBIT→
JW Life Science Stock
JW Life Science Dividend→
JW Life Science Stock
JW Life Science Directors Dealings→
JW Life Science Stock
JW Life Science Stocks→
JW Life Science Stock
JW Life Science Market capitalization→
JW Life Science Stock
JW Life Science Debt→
JW Life Science Stock
JW Life Science Liabilities→
JW Life Science Stock
JW Life Science Equity→
JW Life Science Stock
JW Life Science AAQS→
JW Life Science Stock
JW Life Science Employees→
JW Life Science Stock
JW Life Science ROE→
JW Life Science Stock
JW Life Science ROA→
JW Life Science Stock
JW Life Science ROCE→
JW Life Science Stock
JW Life Science News→
JW Life Science Stock
JW Life Science Analyst Price Targets→

Health Stocks

JW PharmaceuticalJW HoldingsJW ShinyakJW (Cayman) Therapeutics CoJyong BiotechJupiter NeurosciencesK PharmaJupiter Life Line HospitalsKahira Pharmaceuticals and Chemical IndustriesJubilant PharmovaKainos MedicineJTECAll Stocks A–Z →